4
Changes in Ownership
BIODESIX INC Filed Acc 0001140361-22-041077
Chief Accounting Officer sold 1,725 shares at an average $1.03 ($1,779)
- Chief Accounting Officer acquired 5,482 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Siurek Ryan H · Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-08 | Exercise or conversion : show line 1 in the form | +5,482 | 16,724 | D | ||
| 2022-11-09 | Sale : show line 2 in the form | −963 | $1.04 | $1,003 | 15,761 | D |
| 2022-11-10 | Sale : show line 3 in the form | −762 | $1.02 | $775 | 14,999 | D |
| Open-market sales · 1,725 sh · avg $1.03 · $1,779 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-11-08 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −1,925 | 1,925 | 25,047 | D |
| 2022-11-08 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −3,557 | 3,557 | 10,670 | D |
Loading xslF345X03/form4.xml…